These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38500003)

  • 1. A qualitative exploration of the use of telehealth for opioid treatment: Implications for nurse-managed care.
    Heidari O; Winiker AK; Pollock S; Sodder S; Tsui JI; Tobin KE
    J Clin Nurs; 2024 Jul; 33(7):2707-2718. PubMed ID: 38500003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study to determine perspectives of clinicians providing telehealth opioid use disorder treatment.
    Burke B; Miller E; Clear B; Weiner SG
    Drug Alcohol Depend; 2024 Mar; 256():111118. PubMed ID: 38367534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
    Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
    Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.
    McCann C; McCauley CO; Harkin D
    J Adv Nurs; 2024 Jun; 80(6):2500-2511. PubMed ID: 38082475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.
    Lott AM; Danner AN; Malte CA; Williams EC; Gordon AJ; Halvorson MA; Saxon AJ; Hagedorn HJ; Sayre GG; Hawkins EJ
    J Addict Med; 2023 Jul-Aug 01; 17(4):e262-e268. PubMed ID: 37579107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.
    Mattocks KM; Moore DT; Wischik DL; Lazar CM; Rosen MI
    J Subst Abuse Treat; 2022 Aug; 139():108777. PubMed ID: 35346533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse practitioner led telehealth services: A scoping review.
    Charalambous J; Hollingdrake O; Currie J
    J Clin Nurs; 2024 Mar; 33(3):839-858. PubMed ID: 37859576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities.
    Walters SM; Perlman DC; Guarino H; Mateu-Gelabert P; Frank D
    Subst Use Misuse; 2022; 57(7):1144-1153. PubMed ID: 35443862
    [No Abstract]   [Full Text] [Related]  

  • 11. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C; Bailey A; Delorme E; Hano S; Evans EA
    Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative Study.
    Davoust M; Bazzi AR; Blakemore S; Blodgett J; Cheng A; Fielman S; Magane KM; Theisen J; Saitz R; Ventura AS; Weinstein ZM
    Res Sq; 2024 Apr; ():. PubMed ID: 38746460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.
    Chapman SA; Fraimow-Wong L; Phoenix BJ; Tierney M; Spetz J
    J Subst Use Addict Treat; 2024 Feb; 157():209215. PubMed ID: 37979946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
    Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
    J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Telehealth for Diabetes Management in the Deep South of the United States: Qualitative Study of Barriers and Facilitators on the Patient and Clinician Journey.
    Bazzano AN; Patel T; Nauman E; Cernigliaro D; Shi L
    J Med Internet Res; 2024 Jan; 26():e43583. PubMed ID: 37976468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences of Australian primary healthcare nurses in using telehealth during COVID-19: a qualitative study.
    James S; Ashley C; Williams A; Desborough J; Mcinnes S; Calma K; Mursa R; Stephen C; Halcomb EJ
    BMJ Open; 2021 Aug; 11(8):e049095. PubMed ID: 34362804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.
    Lockard R; Priest KC; Gregg J; Buchheit BM
    Subst Abus; 2022; 43(1):1150-1157. PubMed ID: 35499402
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a Novel e-Learning Program for Physiotherapists to Manage Knee Osteoarthritis via Telehealth: Qualitative Study Nested in the PEAK (Physiotherapy Exercise and Physical Activity for Knee Osteoarthritis) Randomized Controlled Trial.
    Jones SE; Campbell PK; Kimp AJ; Bennell K; Foster NE; Russell T; Hinman RS
    J Med Internet Res; 2021 Apr; 23(4):e25872. PubMed ID: 33929326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.
    Morse E; Binswanger IA; Taylor E; Gray C; Stimmel M; Timko C; Harris AHS; Smelson D; Finlay AK
    J Subst Abuse Treat; 2021 Oct; 129():108353. PubMed ID: 34080564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.